Division of Pulmonary, Allergy and Critical Care Medicine

Home

Address:

Columbia University, College of Physicians & Surgeons

Columbia Presbyterian/Eastside
16 East 60th Street, Suite 320
New York, NY 10022-1002

Phone: 212-326-8415

ram7@columbia.edu

Roger A. Maxfield, M.D.

Clinical Professor of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine

Clinical Interests:

Dr. Maxfield's areas of clinical interest are asthma, COPD, lung cancer, and interventional bronchoscopy including ultrasound guided transbronchial needle aspiration (EBUS-TBNA), brachytherapy (endobronchial radiotherapy), argon plasma coagulation (non-contact electrocautery), and stent insertion. He is conducting clinical trials of bronchoscopic lung volume reduction for emphysema and performs evaluations for lung volume reduction surgery. He also sees patients with asbestos exposure and other occupational lung diseases. He is a NIOSH certified B-reader for interpreting chest x-rays for pneumoconiosis.

For additional information about the interventional bronchoscopy program:

Interventional Bronchoscopy Program

Education:

1974 A.B., Brown University
1977 M.D., Brown University School of Medicine
1977-1980 Residency, Internal Medicine, Georgetown University Hospital
1983-1985 Fellowship, Pulmonary Medicine, Bellevue Hospital Center and Manhattan V.A. Hospital

Honors:

USPHS National Health Service Corps Award
Fellowship in American College of Physicians
Fellowship in American College of Chest Physicians

Listed in Castle Connolly, "Top Doctors: New York Metro Area," First to ~~Tenth~~ Eleventh Editions
Listed in New York Magazine, "Best Doctors in New York," June 7, 2000 Issue

Publications:

Goldfarb JP. Gross F. Maxfield R. Rubin M. Janis R. Gastric carcinoid: two unusual presentations. American Journal of Gastroenterology. 78(6):332-4, 1983 June.

Maxfield R.A., Sorkin IB. Fazzini EP. Rapoport DM. Stenson WM. Goldring RM. Respiratory failure in patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Critical Care Medicine. 14(5):443-9, 1986 May.

Maxfield R.A., Aranda CP. The role of fiberoptic bronchoscopy and transbronchial biopsy in the diagnosis of Pancoast's tumor. New York State Journal of Medicine. 87(6):326-9, 1987 June.

Lange, D.J., Murphy, P.L., Maxfield, R.A., Skarvala, A.M., Riedel, G. (1994). Management of patients with amyotrophic lateral sclerosis. J. Neuro. Rehab. 8:21-28.

Maxfield RA. Therapeutic bronchoscopy: Advances in managing lung cancer. J Respir Dis 2001; 22:376-385.

Phillips M, Cataneo RN, Cummin ARC, Gagliardi AJ, Gleeson K, Greenberg J, Maxfield RA, Rom WN. Detection of Lung Cancer with Volatile Markers in the Breath. Chest 2003; 123: 2115-2123.

Maxfield RA. New and emerging minimally invasive techniques for lung volume reduction. Chest 2004;125:777-83

Phillips M, Altorki N, Austin JHM, Cameron RB, Cataneo RN, Greenberg J, Kloss R, Maxfield RA, et al. Prediction of Lung Cancer Using Volatile Biomarkers in Breath. Cancer Biomarkers 2007; 3: 95-109

Lederer DJ, Thomashow BM, Ginsburg ME, Austin JH, Bartels MN, Yip CK, Jellen PA, Brogan FL, Kawut SM, Maxfield RA, DiMango AM, Simonelli PF, Gorenstin LA, Pearson GD, Sonett JR. Lung Volume Reduction Surgery for Pulmonary Emphysema: Improvement of the Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index after One Year. J Thorac Cardiovasc Surg 2007; 133:1434-8

Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Kloss R, Maxfield RA, Munawar MI, Pass HI, Rashid A, Rom WN, Schmitt P, Wai J. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clinica Chimica Acta 2008; 393:76?84